A Study of Megestrol Acetate in HIV-Infected Children

NCT00002182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2005-06-24

No results posted yet for this study

Summary

The purpose of this study is to see if megestrol acetate is safe and effective in treating HIV-infected children with failure to thrive (FTT).

Conditions

  • HIV Infections

Interventions

DRUG

Megestrol acetate

Sponsors & Collaborators

  • Gamma Project - ACTU

    lead OTHER

Study Design

Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002182 on ClinicalTrials.gov